Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia (2018)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidade: FCF
- Subjects: ESTATINAS; HIPERCOLESTEROLEMIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 54, suppl. 2, p. 222 res. 423, 2018
- Conference titles: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF
-
ABNT
HERNANDEZ, Carolina Dagli et al. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 28 out. 2024. , 2018 -
APA
Hernandez, C. D., Borges, J. B., Faludi, A. A., Gonçalves, R. M., Hirata, M. H., & Hirata, R. D. C. (2018). Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf -
NLM
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 out. 28 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf -
Vancouver
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 out. 28 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf - Possivel relação dos polimorfismos no gene ABCB1 com as toxicidades induzidas por cisplatina em pacientes com câncer de cabeça e pescoço
- Tecnologia de proteínas recombinantes
- Fármacos obtidos de anticorpos monoclonais
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
- Extracellular domain of human interferon alpha receptor: isolation of biologically active soluble and inclusion body-derived proteins from escherichia coli
- Novo método de estudo para mutação (G20210A) do gene protombina (G20210A) por RFLP, com controle interno
- Influence of LDL receptor gene polymorphisms on serum lipid levels and response to atorvastatin in subjects with familial and non familial hypercholesterolemia
- Sub cloning fragments dna of the type i inteferon receptor gene using prset a vector
- Padronizacao da reacao de polimerizacao de cadeia (pcr) para genotipagem da apolipoproteina e em humanos
- Estudo da frequencia de minisatelites e microsatelites em dnas humanos para fins de testes de identificacao por pcr
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
